148 related articles for article (PubMed ID: 26928810)
1. In the interests of time: improving HIV allocative efficiency modelling via optimal time-varying allocations.
Shattock AJ; Kerr CC; Stuart RM; Masaki E; Fraser N; Benedikt C; Gorgens M; Wilson DP; Gray RT
J Int AIDS Soc; 2016; 19(1):20627. PubMed ID: 26928810
[TBL] [Abstract][Full Text] [Related]
2. How should HIV resources be allocated? Lessons learnt from applying Optima HIV in 23 countries.
Stuart RM; Grobicki L; Haghparast-Bidgoli H; Panovska-Griffiths J; Skordis J; Keiser O; Estill J; Baranczuk Z; Kelly SL; Reporter I; Kedziora DJ; Shattock AJ; Petravic J; Hussain SA; Grantham KL; Gray RT; Yap XF; Martin-Hughes R; Benedikt CJ; Fraser-Hurt N; Masaki E; Wilson DJ; Gorgens M; Mziray E; Cheikh N; Shubber Z; Kerr CC; Wilson DP
J Int AIDS Soc; 2018 Apr; 21(4):e25097. PubMed ID: 29652100
[TBL] [Abstract][Full Text] [Related]
3. Optimal allocation of HIV resources among geographical regions.
Kedziora DJ; Stuart RM; Pearson J; Latypov A; Dierst-Davies R; Duda M; Avaliani N; Wilson DP; Kerr CC
BMC Public Health; 2019 Nov; 19(1):1509. PubMed ID: 31718603
[TBL] [Abstract][Full Text] [Related]
4. The global Optima HIV allocative efficiency model: targeting resources in efforts to end AIDS.
Kelly SL; Martin-Hughes R; Stuart RM; Yap XF; Kedziora DJ; Grantham KL; Hussain SA; Reporter I; Shattock AJ; Grobicki L; Haghparast-Bidgoli H; Skordis-Worrall J; Baranczuk Z; Keiser O; Estill J; Petravic J; Gray RT; Benedikt CJ; Fraser N; Gorgens M; Wilson D; Kerr CC; Wilson DP
Lancet HIV; 2018 Apr; 5(4):e190-e198. PubMed ID: 29540265
[TBL] [Abstract][Full Text] [Related]
5. Optimizing HIV/AIDS resources in Armenia: increasing ART investment and examining HIV programmes for seasonal migrant labourers.
Kelly SL; Shattock AJ; Kerr CC; Stuart RM; Papoyan A; Grigoryan T; Hovhannisyan R; Grigoryan S; Benedikt C; Wilson DP
J Int AIDS Soc; 2016; 19(1):20772. PubMed ID: 27281790
[TBL] [Abstract][Full Text] [Related]
6. Allocative and implementation efficiency in HIV prevention and treatment for people who inject drugs.
Benedikt C; Kelly SL; Wilson D; Wilson DP;
Int J Drug Policy; 2016 Dec; 38():73-80. PubMed ID: 27883944
[TBL] [Abstract][Full Text] [Related]
7. Kazakhstan can achieve ambitious HIV targets despite expected donor withdrawal by combining improved ART procurement mechanisms with allocative and implementation efficiencies.
Shattock AJ; Benedikt C; Bokazhanova A; Đurić P; Petrenko I; Ganina L; Kelly SL; Stuart RM; Kerr CC; Vinichenko T; Zhang S; Hamelmann C; Manova M; Masaki E; Wilson DP; Gray RT
PLoS One; 2017; 12(2):e0169530. PubMed ID: 28207809
[TBL] [Abstract][Full Text] [Related]
8. Frontloading HIV financing maximizes the achievable impact of HIV prevention.
Anderson SJ; Ghys PD; Ombam R; Hallett TB
J Int AIDS Soc; 2018 Mar; 21(3):e25087. PubMed ID: 29498234
[TBL] [Abstract][Full Text] [Related]
9. The influence of constraints on the efficient allocation of resources for HIV prevention.
Stopard IJ; McGillen JB; Hauck K; Hallett TB
AIDS; 2019 Jun; 33(7):1241-1246. PubMed ID: 30649065
[TBL] [Abstract][Full Text] [Related]
10. A model for allocating CDC's HIV prevention resources in the United States.
Lasry A; Sansom SL; Hicks KA; Uzunangelov V
Health Care Manag Sci; 2011 Mar; 14(1):115-24. PubMed ID: 21184183
[TBL] [Abstract][Full Text] [Related]
11. Reorienting the HIV response in Niger toward sex work interventions: from better evidence to targeted and expanded practice.
Fraser N; Kerr CC; Harouna Z; Alhousseini Z; Cheikh N; Gray R; Shattock A; Wilson DP; Haacker M; Shubber Z; Masaki E; Karamoko D; Görgens M
J Acquir Immune Defic Syndr; 2015 Mar; 68 Suppl 2():S213-20. PubMed ID: 25723987
[TBL] [Abstract][Full Text] [Related]
12. Using allocative efficiency analysis to inform health benefits package design for progressing towards Universal Health Coverage: Proof-of-concept studies in countries seeking decision support.
Fraser-Hurt N; Hou X; Wilkinson T; Duran D; Abou Jaoude GJ; Skordis J; Chukwuma A; Lao Pena C; Tshivuila Matala OO; Gorgens M; Wilson DP
PLoS One; 2021; 16(11):e0260247. PubMed ID: 34843546
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the use of modelling in resource allocation decisions for HIV and TB.
Bowring AL; Ten Brink D; Martin-Hughes R; Fraser-Hurt N; Cheikh N; Scott N
BMJ Glob Health; 2024 Jan; 9(1):. PubMed ID: 38232992
[TBL] [Abstract][Full Text] [Related]
14. How a new funding model will shift allocations from the Global Fund to Fight AIDS, tuberculosis, and malaria.
Fan VY; Glassman A; Silverman RL
Health Aff (Millwood); 2014 Dec; 33(12):2238-46. PubMed ID: 25392001
[TBL] [Abstract][Full Text] [Related]
15. Optimal investment in a portfolio of HIV prevention programs.
Zaric GS; Brandeau ML
Med Decis Making; 2001; 21(5):391-408. PubMed ID: 11575489
[TBL] [Abstract][Full Text] [Related]
16. The Global Fund's resource allocation decisions for HIV programmes: addressing those in need.
Avdeeva O; Lazarus JV; Aziz MA; Atun R
J Int AIDS Soc; 2011 Oct; 14():51. PubMed ID: 22029667
[TBL] [Abstract][Full Text] [Related]
17. Spending of HIV resources in Asia and Eastern Europe: systematic review reveals the need to shift funding allocations towards priority populations.
Craig AP; Thein HH; Zhang L; Gray RT; Henderson K; Wilson D; Gorgens M; Wilson DP
J Int AIDS Soc; 2014; 17(1):18822. PubMed ID: 24572053
[TBL] [Abstract][Full Text] [Related]
18. The City of Johannesburg can end AIDS by 2030: modelling the impact of achieving the Fast-Track targets and what it will take to get there.
Stuart RM; Fraser-Hurt N; Kerr CC; Mabusela E; Madi V; Mkhwanazi F; Pillay Y; Barron P; Muzah B; Matsebula T; Gorgens M; Wilson DP
J Int AIDS Soc; 2018 Jan; 21(1):. PubMed ID: 29359533
[TBL] [Abstract][Full Text] [Related]
19. Costs of providing HIV care and optimal allocation of HIV resources in Guyana.
Suraratdecha C; Stuart RM; Edwards M; Moore R; Liu N; Wilson DP; Albalak R
PLoS One; 2020; 15(10):e0238499. PubMed ID: 33119591
[TBL] [Abstract][Full Text] [Related]
20. Maximising the effect of combination HIV prevention through prioritisation of the people and places in greatest need: a modelling study.
Anderson SJ; Cherutich P; Kilonzo N; Cremin I; Fecht D; Kimanga D; Harper M; Masha RL; Ngongo PB; Maina W; Dybul M; Hallett TB
Lancet; 2014 Jul; 384(9939):249-56. PubMed ID: 25042235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
